Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jan 2020 for Audentes Therapeutics, Inc., €9.9M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Thomas P. Soloway: trading record in brief
All filings by Thomas P. Soloway on record concern Audentes Therapeutics, Inc. The record holds 10 filings, for trades running from 6 February 2019 to 15 January 2020.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 15 January 2020: a transaction of €9.9M, in Audentes Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas P. Soloway
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
183,384 shares@ US$60.0081.6% of flowCommon StockSEC:0001209191-20-003437:0
144,669 shares@ US$2.763.0% of flowCommon StockSEC:0001209191-20-003111:0
6,219 shares@ US$15.260.7% of flowCommon StockSEC:0001209191-20-003111:1
8,681 shares@ US$59.373.8% of flowCommon StockSEC:0001209191-19-060731:0
41,321 shares@ US$2.760.8% of flowCommon StockSEC:0001209191-19-060731:1
21,458 shares@ US$59.379.4% of flowCommon StockSEC:0001209191-19-060731:2
505 shares@ US$59.210.2% of flowCommon StockSEC:0001209191-19-059743:0
505 shares@ US$31.020.1% of flowCommon StockSEC:0001209191-19-048882:0
1,009 shares@ US$37.310.3% of flowCommon StockSEC:0001209191-19-035578:0
23,333 shares0Common StockSEC:0001209191-19-008678:0
10 of 10 declarations
